Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding AU:CURE?
Track your performance easily
AU:CURE Price & Analysis
CURE ETF Chart & Stats
Day’s Range― - ―
52-Week Range34.75 - 54.00
Previous Close51.25
VolumeN/A
Average Volume (3M)1.50K
AUM42.25M
NAV50.88
Expense Ratio0.45%
Holdings CountN/A
Beta0.91
Inception DateNov 08, 2018
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.07
10 Day Avg. Volume972
30 Day Avg. Volume1,496
Alpha0.00016
Global X S&P Biotech ETF (CURE) Fund Flow Chart
Global X S&P Biotech ETF (CURE) 1 year Net Flows: -4M
CURE ETF FAQ
What was AU:CURE’s price range in the past 12 months?
AU:CURE lowest ETF price was 34.75 and its highest was 54.00 in the past 12 months.
What is the AUM of AU:CURE?
As of Aug 22, 2024 The AUM of AU:CURE is 42.25M.
Is AU:CURE overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does AU:CURE pay dividends?
AU:CURE does not currently pay dividends.
How many shares outstanding does AU:CURE have?
Currently, no data Available
Which hedge fund is a major shareholder of AU:CURE?
Currently, no hedge funds are holding shares in AU:CURE
ETF Description
Global X S&P Biotech ETF
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.